ONWARD_Logotype®_Red.png
ONWARD® Medical Publishes Annual Sustainability Summary
July 17, 2024 01:30 ET | ONWARD Medical NV
ONWARD® Medical Publishes Annual Sustainability Summary
ONWARD_Logotype®_Red.png
ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy
July 09, 2024 13:18 ET | ONWARD Medical NV
ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy
ONWARD_Logotype®_Red.png
ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC
June 28, 2024 17:53 ET | ONWARD Medical NV
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Runway Growth Capital LLC is a leading U.S.-based specialty...
ONWARD_Logotype®_Red.png
ONWARD® Medical Announces Participation in Stifel European Healthcare Summit
June 26, 2024 01:30 ET | ONWARD Medical NV
ONWARD® Medical Announces Participation in Stifel European Healthcare Summit
ONWARD_Logotype®_Red.png
ONWARD® Medical to Highlight Brain-Computer Interface at HLTH Europe Conference
June 18, 2024 01:30 ET | ONWARD Medical NV
ONWARD® Medical to Highlight Brain-Computer Interface at HLTH Europe Conference
ONWARD_Logotype®_Red.png
ONWARD® Medical Announces Results of Annual General Meeting of Shareholders
June 13, 2024 17:36 ET | ONWARD Medical NV
ONWARD® Medical Announces Results of Annual General Meeting of Shareholders: shareholders approve all proposed resolutions
ONWARD_Logotype®_Red.png
ONWARD® Medical berichtet über das 1. Quartal 2024 und die bisherigen Höhepunkte des Jahres
May 23, 2024 21:19 ET | ONWARD Medical NV
Ergebnisse der Up-LIFT-Zulassungsstudie in Nature Medicine veröffentlicht Einreichung des De-Novo-Antrags für das ARC-EX®-System bei der FDA  Erfolgreiche Einwerbung von 20 Mio. EUR an Eigenkapital ...
ONWARD_Logotype®_Red.png
ONWARD® Medical fait le point sur le premier trimestre 2024 et sur les faits marquants de l’année écoulée
May 23, 2024 21:19 ET | ONWARD Medical NV
La revue Nature Medicine a publié les résultats de l’essai clinique pivot Up-LIFT Dépôt auprès de la FDA d’une demande de classification du dispositif ARC-EX® System basée sur les risques (demande...
ONWARD_Logotype®_Red.png
ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights
May 23, 2024 01:30 ET | ONWARD Medical NV
ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights
ONWARD_Logotype®_Red.png
ONWARD® Medical veranstaltet Webcast zu Einzelheiten der Up-LIFT-Studie und der aktuellen Veröffentlichung in Nature Medicine
May 22, 2024 13:13 ET | ONWARD Medical NV
Ergebnisse der Up-LIFT-Zulassungsstudie in Nature Medicine veröffentlicht Besprechung der Ergebnisse der Zulassungsstudie in einem Webcast in dieser Woche mit Führungskräften des Unternehmens,...